This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Progesterone Treatment of Blunt Traumatic Brain Injury

This study has been completed.
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by (Responsible Party):
David Wright, Emory University Identifier:
First received: November 4, 2002
Last updated: September 17, 2014
Last verified: September 2014
The purpose of this study is to determine if progesterone treatment safely reduces brain swelling and damage after injury.

Condition Intervention Phase
Traumatic Brain Injury Drug: IV Progesterone Phase 1 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: ProTECT: Single Center, Phase II (Pilot), Double Blind, 4:1 Randomized, Placebo Controlled Clinical Trial for Progesterone Treatment of Moderate and Severe Blunt TBI

Resource links provided by NLM:

Further study details as provided by David Wright, Emory University:

Primary Outcome Measures:
  • neurological outcome [ Time Frame: 30 days ]
    GOS, DRS, and GOAT

Enrollment: 100
Study Start Date: May 2002
Study Completion Date: September 2005
Primary Completion Date: September 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: placebo
Drug: IV Progesterone
Experimental: IV progesterone
IV progesterone
Drug: IV Progesterone

  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Blunt head trauma occuring within 11 hours
  • Ages 18 years and older (or Tanner Score of 5)
  • Index GCS between 4 and 12

Exclusion Criteria:

  • Spinal cord injury
  • Penetrating head trauma
  • Cardiopulmonary arrest upon ECC arrival
  • Status Epilepticus upon ECC arrival
  • Systolic BP < 90mmHG upon ECC arrival
  • Pulse Ox of < 90 (or pO2 < 60)
  • Prisoners or incarcerated individuals
  • Past Hx of significant intercranial pathology
  • Pregnant females
  • Blood alcohol level > 250 mg/dl
  • Non-English speakers (a Spanish version of the ICF is currently being developed)
  • Allergy(s) to soy, egg, or progesterone
  • Active breast or reproductive organ cancer(s)
  • Previous head injury or stroke within the past 6 weeks
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00048646

United States, Georgia
Emory University School of Medicine - Dept. of Emergency Medicine
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
David Wright
National Institute of Neurological Disorders and Stroke (NINDS)
Principal Investigator: Arthur L Kellermann, MD, MPH Chairman - Emory University Dept. of Emergency Medicine
  More Information

Responsible Party: David Wright, Co-Investigator, Project Lead, Emory University Identifier: NCT00048646     History of Changes
Other Study ID Numbers: 0433-2001
1R01NS039097-01A1 ( U.S. NIH Grant/Contract )
Study First Received: November 4, 2002
Last Updated: September 17, 2014

Keywords provided by David Wright, Emory University:

Additional relevant MeSH terms:
Brain Injuries
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs processed this record on July 21, 2017